Literature DB >> 20170346

Longitudinal changes of adiponectin, carbohydrate and lipid metabolism in pregnant women at high risk for gestational diabetes.

Giancarlo Paradisi1, Francesca Ianniello, Claudia Tomei, Marina Bracaglia, Brigida Carducci, Maria Rosaria Gualano, Giuseppe La Torre, Maria Banci, Alessandro Caruso.   

Abstract

To evaluate, in pregnant women at high risk for gestational diabetes (GDM), the longitudinal changes of adiponectin, carbohydrate and lipid metabolism, and to assess their independent value as risk factors for the development of GDM. Fifty women at beginning of pregnancy were studied. Adiponectin, insulin sensitivity (homeostasis model assessment, HOMA) and lipid panel were measured at 1st, 2nd and 3rd trimesters of pregnancy. Twelve patients developed GDM. In both groups, GDM and normal glucose tolerance (NGT), adiponectin decreased from 1st to 2nd and 3rd trimesters by about 5 and 20% (GDM, p < 0.05), and of about 17 and 25% in NGT (p < 0.05), respectively. Values observed in NGT were similar to those of GDM (F = 9.401; p = 0.238). The Cox regression model identified as the strongest independent risk factor for GDM HOMA over 1.24 (RR = 14.12) at 1st trimester, fasting glycaemia over 87 mg/dl (RR = 42.68) triglycerides over 158 mg/dl (RR = 5.87) and body mass index (BMI) over 27 kg/m(2) (RR = 4.38) at 2nd trimester. Adiponectin in high-risk women is characterised by a constant reduction throughout gestation, irrespective of the development of GDM. HOMA, fasting glycaemia, triglycerides and BMI, but not adiponectin are independent predictors of GDM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20170346     DOI: 10.3109/09513591003632084

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  18 in total

Review 1.  MALDI Imaging mass spectrometry: current frontiers and perspectives in pathology research and practice.

Authors:  Michaela Aichler; Axel Walch
Journal:  Lab Invest       Date:  2015-01-26       Impact factor: 5.662

Review 2.  Adipokine levels during the first or early second trimester of pregnancy and subsequent risk of gestational diabetes mellitus: A systematic review.

Authors:  Wei Bao; Aileen Baecker; Yiqing Song; Michele Kiely; Simin Liu; Cuilin Zhang
Journal:  Metabolism       Date:  2015-01-29       Impact factor: 8.694

3.  Assessment of different sample preparation routes for mass spectrometric monitoring and imaging of lipids in bone cells via ToF-SIMS.

Authors:  Kaija Schaepe; Julia Kokesch-Himmelreich; Marcus Rohnke; Alena-Svenja Wagner; Thimo Schaaf; Sabine Wenisch; Jürgen Janek
Journal:  Biointerphases       Date:  2015-03-19       Impact factor: 2.456

4.  Plasma concentrations of lipids during pregnancy and the risk of gestational diabetes mellitus: A longitudinal study.

Authors:  Wei Bao; Sharon Dar; Yeyi Zhu; Jing Wu; Shristi Rawal; Shanshan Li; Natalie L Weir; Michael Y Tsai; Cuilin Zhang
Journal:  J Diabetes       Date:  2017-09-29       Impact factor: 4.006

Review 5.  Mass spectrometry imaging with high resolution in mass and space.

Authors:  Andreas Römpp; Bernhard Spengler
Journal:  Histochem Cell Biol       Date:  2013-05-08       Impact factor: 4.304

6.  First-trimester prediction of gestational diabetes mellitus: examining the potential of combining maternal characteristics and laboratory measures.

Authors:  Makrina Savvidou; Scott M Nelson; Mahlatse Makgoba; Claudia-Martina Messow; Naveed Sattar; Kypros Nicolaides
Journal:  Diabetes       Date:  2010-09-28       Impact factor: 9.461

7.  The association of circulating adiponectin and + 45 T/G polymorphism of adiponectin gene with gestational diabetes mellitus in Iranian population.

Authors:  Mohammad Ali Takhshid; Zinab Haem; Farzaneh Aboualizadeh
Journal:  J Diabetes Metab Disord       Date:  2015-04-16

8.  Maternal obesity is associated with the formation of small dense LDL and hypoadiponectinemia in the third trimester.

Authors:  Barbara J Meyer; Frances M Stewart; Elizabeth A Brown; Josephine Cooney; Solveig Nilsson; Gunilla Olivecrona; Jane E Ramsay; Bruce A Griffin; Muriel J Caslake; Dilys J Freeman
Journal:  J Clin Endocrinol Metab       Date:  2013-01-21       Impact factor: 5.958

9.  Adiponectin: are measurements clinically useful in pregnancy?

Authors:  Sylvie Hauguel-de Mouzon; Patrick Catalano
Journal:  Diabetes Care       Date:  2013-06       Impact factor: 19.112

10.  Lower adiponectin levels at first trimester of pregnancy are associated with increased insulin resistance and higher risk of developing gestational diabetes mellitus.

Authors:  Marilyn Lacroix; Marie-Claude Battista; Myriam Doyon; Julie Ménard; Jean-Luc Ardilouze; Patrice Perron; Marie-France Hivert
Journal:  Diabetes Care       Date:  2013-01-08       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.